We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tern Plc | LSE:TERN | London | Ordinary Share | GB00BFPMV798 | ORD 0.02P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 7.69% | 1.40 | 1.30 | 1.50 | 1.40 | 1.30 | 1.30 | 1,678,053 | 10:05:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 199k | -12.61M | -0.0291 | -0.48 | 5.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/10/2024 13:02 | re DA That is their clients turnover by the way. So they will be turning over 40 X more, say $4M ,guess a net profit of around $400,000, Tern has roughly a third holding, on paper a bonus- doubt if the will see it though- say $120,000. All over a years period- too late. Pie in the sky though. Odd that no real financial details leak out, maybe there are none? | emigna2020 | |
05/10/2024 12:10 | Talking Medicines, a healthcare intelligence company that uses AI and data science, reported record revenue bookings in the first quarter of 2024. The company expects revenue to grow significantly in 2024, with new clients potentially increasing revenue from around $100,000 to 30–40 times that level. In the first quarter of 2024, Talking Medicines reported record revenue bookings. Clients Talking Medicines has secured clients with a combined turnover of $13 billio | kkrriiss2 | |
05/10/2024 11:52 | If you download pdf Cyberark tells you why we integrated Keyscaler | kkrriiss2 | |
05/10/2024 11:32 | Good Week for Tern holders UP nearly 50% from the lows, just need to sort out what they are going to do on financing and if they need it before either an IPO or bid for something. Who knows what Sisto is thinking or planning, D/A is obviously making money hence no need for the second tranche so that seems to be gaining traction thanks to 10/11 personnel now on the board and helping sells. D/A seem to be a big part of CyberArk solutions and that has to be where a lot of the revenue is coming from SBOMs etc. All a waiting game now until a suitor comes along could be very soon, I think D/A know this hence the pulling of the second tranche!!. | wardy333 | |
05/10/2024 10:03 | Device Authority’s CEO, Darron Antill, will be speaking at this month’s IoT Security Foundation Conference His presentation, "Securing the Future: Harnessing the Power of Ecosystems in IoT Security", will explore the crucial role of connected ecosystems in safeguarding IoT devices and the future of security. Don’t miss the chance to hear Darron’s insights into the ever-evolving landscape of IoT security. | andrbea | |
05/10/2024 10:01 | We're excited to introduce our groundbreaking integration with CyberArk, extending their industry-leading Privileged Access Management (PAM) capabilities to IoT/OT devices, providing secure access to critical assets on the factory floor and effectively unifying IT/OT security posture. Device Authority 4 days ago CyberArk and Device Authority have joined forces to extend privileged access management to hashtag#IoT and hashtag#OT devices. This strategic partnership bridges the gap between IT and OT security, enhancing visibility, compliance, and protecting critical assets from cyber threats. Learn more about how this integration is shaping the future of hashtag#CyberSecurit | andrbea | |
05/10/2024 09:59 | The second version of our Apple Vision Pro App is here! The app encourages users to explore the endless potential of spatial computing in medical education, in a fully immersive setting. “With this release, we are redefining the future of medical training by making it more accessible and immersive than ever before,” Richard Vincent, Co-Founder and CEO, FundamentalVR Download our App in the VisionOS App Store today: | andrbea | |
04/10/2024 14:26 | Thank you jimbob48, hadn't realised that had come around already | onsideman | |
04/10/2024 14:13 | First day of trading in Wyld excluding right to receive unit rights -according to timetable re Wyld Rights Issue at foot of Tern RNS re Wyld dated 2nd Sept. So probably opened at 9 or 10 SEK. | jimbob58 | |
04/10/2024 13:53 | I'm currently away with only intermittent data coverage, but can someone clarify what the Wyld share price is doing? On investing.com it suggests up 50% odd but from a base way below that at which it closed the last time I looked a couple of days ago? | onsideman | |
04/10/2024 13:31 | Deoends where you google it. I’ve seen up 28% and 60% down 69% and down 99%. I can’t make head ne tail. But I don’t have any Wyld shares so not following it closely. | bingoprize | |
04/10/2024 12:19 | I'm seeing it down 30% lol...... | ohsod1t | |
04/10/2024 11:53 | I'm seeing wyld up 63% ???That can't be right ? | cambradjones | |
04/10/2024 11:35 | 'KeyScaler AI' coming in the next couple of months, says Mr Benson (DA) in the link of post 354994 | andrbea | |
04/10/2024 10:39 | Current buy to sell ratio 50/1... | wardy333 | |
04/10/2024 10:34 | surge past 2p and it's game on.. Will any prospective DA buyer look to grab 30% on the cheap via Tern ??? a no brainer !!! | still waiting | |
04/10/2024 10:31 | A DA podcast, from 2 weeks ago (Keyscaler) | andrbea | |
04/10/2024 10:17 | An event they're (DA) attending next month | andrbea | |
04/10/2024 10:06 | C.Mon Tern. | kumala | |
04/10/2024 08:34 | L2 strengthening. | jonc | |
04/10/2024 06:49 | I THANK YOU!!!!! | i will always own you | |
04/10/2024 06:48 | And who was right all along???? | i will always own you | |
04/10/2024 06:46 | Bless. JUST BLESS. | i will always own you | |
04/10/2024 06:46 | I hear ya tears ya utter headcase | i will always own you |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions